We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Xcel Sues Par Pharma Unit Over ANDA For Diastat Generic

Law360 (July 9, 2004, 12:00 AM EDT) -- Xcel Pharmaceuticals has filed a lawsuit against Par Pharmaceuticals subsidiary Kali Laboratories over Kali's filing of an abbreviated new drug application (ANDA) for a generic version of the rectal gel Diastat....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.